Use of recombinant erythropoietin in thalassemic patients on dialysis

We studied the therapeutic benefit of recombinant human erythropoietin (rHuEPO) in dialysis patients with thalassemia minor. Four of the 40 randomly selected patients (22 on hemodialysis [HD], 18 on continuous ambulatory peritoneal dialysis [CAPD]) were identified to be thalassemic prior to a trial...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 1992-03, Vol.19 (3), p.239-245
Hauptverfasser:	KAR NENG LAI, KONG CHIU WONG, LI, P. K. T, SIU FAI LIU
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Drug Evaluation Erythropoietin - therapeutic use Female Hormones. Endocrine system Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Medical sciences Peritoneal Dialysis, Continuous Ambulatory Pharmacology. Drug treatments Recombinant Proteins - therapeutic use Renal Dialysis Thalassemia - complications Thalassemia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!